Evaluation of the Methods of Treatment of Essential Hypertension

REFERENCES

• Evelyn, K. S.: Pathogenesis, clinico-pathological correlation and treatment of hypertension. McGill M. J. 22:225–260 (December) 1953.
   PubMedGoogle Scholar
• Perera, George: Hypertensive disease without hypertension. In: Ciba Foundation Symposium on Hypertension. Boston, Little, Brown and Company, 1954, pp. 46–50.
   Google Scholar
• Goldring, William: Definition of hypertensive disease (essential hypertension). In: Symposium on Essential Hypertension. Boston, Wright and Potter Printing Company, 1951, pp. 54–60.
   Google Scholar
• Pickering, G. W.: Blood Pressure. New York, Grune & Stratton, 1955, pp. 241–248.
   Google Scholar
• Page, I. H.: Discussion of article by Dr. George Perera. Ibid. 2.
   Google Scholar
• Frank, E.: Bestchen beziehungen zwischen chromaffinem System und der chronischen Hypertonie des Menschen. Deutsche Arch. f. klin. Med. 103:397–412, 1911.
   Google Scholar
• Volhard, F. and Fahr, T.: Die Brightische Nierenkrankheit, Klinis Pathologic und Atlas. Berlin, Julius Springer, 1914.
   Google Scholar
• Wagener. H. P. and Keith, N. M.: Diffuse arteriolar disease with hypertension and the associated retinal lesions. Medicine 18:317–430 (September) 1939.
   Google Scholar
• Smithwick, R. H.: The effect of sympathectomy upon the mortality and survival rates of patients with hypertensive cardiovascular disease. In: Hypertension, a Symposium. Minneapolis, University of Minnesota Press, 1951, pp. 429–448.
   Google Scholar
• Murphy, F. D.: Diagnosis and treatment of arterial hypertension. Postgrad. Med. 2:422–430 (December) 1947.
   PubMedGoogle Scholar
• Master, Arthur and Jaffe, H. L.: New criteria in management of essential hypertension. Postgrad. Med. 14:66–74 (July) 1953.
   PubMedGoogle Scholar
• Widal, F.: La cure de déchloruration; son action à certaines périodes de la néphrite epithéliale. Semaine méd. 23:219, 1903.
   Google Scholar
• Blum, L., Aubel, E. and Hausknecht, R.: Le mécanisme dé l'action de chlorure de sodium et du chlorure de potassium dans les néphrites hydropigenes. Compt. rend. Soc. de biol. 85:123–125, 1921.
   Google Scholar
• Magnus-Levy, A: Alkalichloride und Alkalikarbonate bei Oedemen. Deutsche med. Wchnschr. 46:594–596, 1920.
   Google Scholar
• Vogel, P.: Uber Regulation des Körpergewichtes. Verhandl. d. deutsch. Gesellsch. f. inn. Med. 43:51–55, 1931.
   Google Scholar
• Allen, E. N.: Arterial hypertension. J.A.M.A. 74:652–655 (March 6) 1920.
   Google Scholar
• Martini, P. and Kaiser, K.: The importance of sodium chloride and its ions in the production and the treatment of hypertension. In: Ciba Foundation Symposium on Hypertension: Humoral and Neurogenic Factors. Boston, Little, Brown and Company, 1954, pp. 272–285.
   Google Scholar
• Kempner, Walter: Treatment of hypertensive vascular disease with rice diet. Am. J. Med. 4:545–577 (April) 1948.
   PubMed Web of Science ®Google Scholar
• Newborc, Barbara and Kempner, Walter: Analysis of 177 cases of hypertensive vascular disease with papilledema. One hundred twenty-six patients treated with rice diet. Am. J. Med. 19:33–47 (July) 1955.
   PubMed Web of Science ®Google Scholar
• Watkin, D. M., Froeb, H. F., Hatch, F. T. and Gutman, A. B.: Effects of diet in essential hypertension. II. Results with unmodified Kempner rice diet in 50 hospitalized patients. Am. J. Med. 9:441–493 (October) 1950.
   Google Scholar
• Goldring, William: Cornell Conferences on Therapy: Medical management of hypertension. New York State J. Med. 50:2559–2566 (November 1) 1950.
   PubMedGoogle Scholar
• Gold, Harry: Ibid. 21.
   Google Scholar
• Markovitz, Meyer, Koik, J. V., Hick, F. K. and Grissom, R. L.: Hexamethonium, hydralazine and Rauwolfia serpentina in hypertension. Am. J. M. Sc. 229:486–495 (May) 1955.
   Web of Science ®Google Scholar
• Wilkins, R. W.: Essential hypertension with special reference to drug treatment. Disease-a-Month, February 1955.
   Google Scholar
• Grimson, K. S.: Drugs recently introduced for hypertension. J.A.M.A. 158:359–367 (June 4) 1955.
   PubMed Web of Science ®Google Scholar
• Dustan, Harriet P.: Rheumatic and febrile syndrome during prolonged hydralazine treatment. J.A.M.A. 154:23–29 (January 2) 1954.
   PubMed Web of Science ®Google Scholar
• Koepsell, J. E., Kuzma, J. F. and Murphy, F. D.: Hypertensive cardiovascular disease (acute) (malignant hypertension): Clinical and pathologic study of 39 cases. Arch. Int. Med. 85:432–458 (March) 1950.
   Google Scholar
• Kirkendall, W. M. and Culbertson, J. W.: Management of systemic arterial hypertension. Arch. Int. Med. 95:601–613 (April) 1955.
   Google Scholar
• Huntington, Ione and Evans, J. A.: Results of splanchnicectomy on patients with hemorrhagic hypertensive retinitis. New England J. Med. 253:398–403 (September 8) 1955.
   PubMed Web of Science ®Google Scholar
• Green, D. M., Nelson, J. N., Dodds, G. A. and Smalley, R. E.: Bilateral adrenalectomy in malignant hypertension and diabetes. J.A.M.A. 144:439–443 (October 7) 1950.
   PubMed Web of Science ®Google Scholar
• Jeffers, W. A., Zintel, H. A., Hafkenschiel, J. H., Hills, A. G., Sellers, A. M. and Wolferth, C. C.: The clinical course, following adrenal resection and sympathectomy, of 82 patients with severe hypertension. Ann. Int. Med. 39:254–266 (August) 1953.
   PubMed Web of Science ®Google Scholar
• Bowers, R. F.: Bilateral adrenalectomy for severe hypertension. J.A.M.A. 154:394–397 (January 30) 1954.
   PubMed Web of Science ®Google Scholar
• Corcoran, A. C., Dustan, H. P., Taylor, R. D. and Page, I. H.: Management of hypertensive disease. Am. J. Med. 17:383–394 (September) 1954.
   PubMed Web of Science ®Google Scholar
• Doyle, A. E., McQueen, E. G. and Smirk, F. H.: Treatment of hypertension with reserpine, with reserpine in combination with pentapyrrolidinium, and with reserpine in combination with Veratrum alkaloids. Circulation 11:170–181 (February) 1955.
   PubMed Web of Science ®Google Scholar
• Smirk, F. H.: Blood pressure reduction in arterial hypertension by hexamethonium and pentapyrrolidinium salts. Am. J. Med. 17:839–850 (December) 1954.
   PubMed Web of Science ®Google Scholar
• Schroeder, H. A.: Hypertensive vascular disease: Therapy with modern drugs and its limits. J. Chron. Dis. 1:497–515 (May) 1955.
   PubMedGoogle Scholar
• Perera, G. A.: Hypertensive vascular disease: Therapeutic principles and objectives. J. Chron. Dis. 1:472–476 (May) 1955.
   PubMedGoogle Scholar
• Hughes, W. M., Dennis, Edward and Moyer, J. H.: Treatment of hypertension with oral reserpine alone and in combination with hydralazine or hexamethonium. Am. J. M. Sc. 229:121–134 (February) 1955.
   Web of Science ®Google Scholar
• Perry, H. M., Jr. and Schroeder, H. A.: The use of pentolinium tartrate with and without hydralazine in the treatment of severe hypertension. New England J. Med. 252:1057–1066 (June 23) 1955.
   PubMed Web of Science ®Google Scholar
• Palmer, R. S.: Essential hypertension: A selected review and commentary. New England J. Med. 252:940–947 (June 2) 1955.
   PubMed Web of Science ®Google Scholar
• Vakil, R. J.: Rauwolfia serpentina in treatment of high blood pressure. Acta med. Scandinav. 152:107–114, 1955.
   PubMedGoogle Scholar
• Fishberg, A. M.: Hypertension and Nephritis. Philadelphia, Lea & Febiger, 1954, p. 886.
   Google Scholar
• Saphire, E. J.: A clinical evaluation of oral Veriloid in the treatment of hypertensive disease. Ann. Int. Med. 41:1211–1224 (December) 1954.
   PubMed Web of Science ®Google Scholar
• Smirk, F. H.: Practical details of treatment of hypertension by hexamethonium salts and by pentamethylene, 1:5-bis-(N-methylpyrrolidinium) bitartrate (M & B 2050A). New Zealand M. J. 52:325–348 (October) 1953.
   PubMedGoogle Scholar
• Schroeder, H. A.: Why not control hypertension with drugs? Clin. Research Proc. 3:1–5 (February) 1955.
   Google Scholar